Patient-Reported Outcomes Improved Through Earlier Initiation of MS Treatment
Using a cohort of more than 2500 patients with MS on disease-modifying therapies, treatment initiation within the first 2 years of disease onset was more beneficial on patient-reported outcomes than 2-4 years postonset.
https://www.neurologylive.com/view/p...n-ms-treatment
Using a cohort of more than 2500 patients with MS on disease-modifying therapies, treatment initiation within the first 2 years of disease onset was more beneficial on patient-reported outcomes than 2-4 years postonset.
https://www.neurologylive.com/view/p...n-ms-treatment
Comment